AU7511800A - Novel target for antiparasitic agents and inhibitors thereof - Google Patents

Novel target for antiparasitic agents and inhibitors thereof

Info

Publication number
AU7511800A
AU7511800A AU75118/00A AU7511800A AU7511800A AU 7511800 A AU7511800 A AU 7511800A AU 75118/00 A AU75118/00 A AU 75118/00A AU 7511800 A AU7511800 A AU 7511800A AU 7511800 A AU7511800 A AU 7511800A
Authority
AU
Australia
Prior art keywords
inhibitors
antiparasitic agents
novel target
novel
target
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Abandoned
Application number
AU75118/00A
Inventor
Johan Thevelein
Patrick Van Dijck
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Katholieke Universiteit Leuven
Original Assignee
Katholieke Universiteit Leuven
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from EP99202805A external-priority patent/EP1081232A1/en
Application filed by Katholieke Universiteit Leuven filed Critical Katholieke Universiteit Leuven
Publication of AU7511800A publication Critical patent/AU7511800A/en
Abandoned legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
    • C12Q1/34—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving hydrolase
    • C12Q1/42—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving hydrolase involving phosphatase
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
    • C12Q1/02—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving viable microorganisms
    • C12Q1/18—Testing for antimicrobial activity of a material

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Wood Science & Technology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Zoology (AREA)
  • Engineering & Computer Science (AREA)
  • Immunology (AREA)
  • Biochemistry (AREA)
  • Microbiology (AREA)
  • Molecular Biology (AREA)
  • Analytical Chemistry (AREA)
  • Biotechnology (AREA)
  • Physics & Mathematics (AREA)
  • Biophysics (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • General Engineering & Computer Science (AREA)
  • General Health & Medical Sciences (AREA)
  • Genetics & Genomics (AREA)
  • Toxicology (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
AU75118/00A 1999-08-30 2000-08-29 Novel target for antiparasitic agents and inhibitors thereof Abandoned AU7511800A (en)

Applications Claiming Priority (5)

Application Number Priority Date Filing Date Title
EP99202805A EP1081232A1 (en) 1999-08-30 1999-08-30 Novel target for antifungals
EP99202805 1999-08-30
EP00870145 2000-06-27
EP00870145 2000-06-27
PCT/EP2000/008410 WO2001016357A2 (en) 1999-08-30 2000-08-29 Novel target for antiparasitic agents and inhibitors thereof

Publications (1)

Publication Number Publication Date
AU7511800A true AU7511800A (en) 2001-03-26

Family

ID=26074264

Family Applications (1)

Application Number Title Priority Date Filing Date
AU75118/00A Abandoned AU7511800A (en) 1999-08-30 2000-08-29 Novel target for antiparasitic agents and inhibitors thereof

Country Status (3)

Country Link
EP (1) EP1206568A2 (en)
AU (1) AU7511800A (en)
WO (1) WO2001016357A2 (en)

Families Citing this family (28)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2819507B1 (en) * 2001-01-17 2007-09-28 Inst Rech Developpement Ird SUBSTITUTED QUINOLINES FOR THE TREATMENT OF PROTOZOAN AND RETROVIRUS CO-INFECTIONS
JP2002338538A (en) * 2001-05-21 2002-11-27 Takeda Schering-Plough Animal Health Kk New sulfonamide derivative and antiparasitic agent containing the same and used for fishes
WO2003025218A2 (en) * 2001-09-21 2003-03-27 K.U.Leuven Research & Development Methods and yeast strains for screening antifungal agents
US7119072B2 (en) 2002-01-30 2006-10-10 Boehringer Ingelheim (Canada) Ltd. Macrocyclic peptides active against the hepatitis C virus
FR2835253B1 (en) * 2002-01-31 2008-02-01 Pape Patrice Le COMPOUNDS, ESPECIALLY FROM UREA DERIVATIVES OR ESTERS OF HALOACETAMIDOBENZOIC ACID AND THEIR USE FOR THE TREATMENT OF PARASITIC DISEASES
US6642204B2 (en) 2002-02-01 2003-11-04 Boehringer Ingelheim International Gmbh Hepatitis C inhibitor tri-peptides
US7091184B2 (en) 2002-02-01 2006-08-15 Boehringer Ingelheim International Gmbh Hepatitis C inhibitor tri-peptides
US20040171073A1 (en) * 2002-10-08 2004-09-02 Massachusetts Institute Of Technology Compounds for modulation of cholesterol transport
US20050075279A1 (en) 2002-10-25 2005-04-07 Boehringer Ingelheim International Gmbh Macrocyclic peptides active against the hepatitis C virus
US7642277B2 (en) 2002-12-04 2010-01-05 Boehringer Ingelheim International Gmbh Non-nucleoside reverse transcriptase inhibitors
UY28323A1 (en) 2003-05-21 2004-12-31 Boehringer Ingelheim Int INHIBITING COMPOUNDS OF HEPATITIS C
JP2005065692A (en) * 2003-08-07 2005-03-17 Nippon Kayaku Co Ltd Method for simply detecting endoplasmic reticulum stress and its use
PE20050431A1 (en) 2003-09-22 2005-07-19 Boehringer Ingelheim Int MACROCYCLIC PEPTIDES ACTIVE AGAINST HEPATITIS C VIRUS
ES2358333T3 (en) 2004-01-21 2011-05-09 Boehringer Ingelheim International Gmbh MACROCYCLIC PEPTIDES WITH ACTION AGAINST THE VIRUS OF HEPATITIS C.
UY29016A1 (en) 2004-07-20 2006-02-24 Boehringer Ingelheim Int ANALOGS OF INHIBITING DIPEPTIDES OF HEPATITIS C
WO2006007708A1 (en) 2004-07-20 2006-01-26 Boehringer Engelheim International Gmbh Hepatitis c inhibitor peptide analogs
WO2007019180A2 (en) * 2005-08-04 2007-02-15 Science & Technology Corporation @ Unm Compounds for binding to eralpha/beta and gpr30, methods of treating disease states and conditions mediated through these receptors and identification thereof
WO2007015632A1 (en) * 2005-08-04 2007-02-08 Cgk Co., Ltd. Atm and atr inhibitor
ATE530570T1 (en) 2006-02-28 2011-11-15 Suntory Holdings Ltd GENE CODING FOR TREHALOSE-6-PHOSPHATE PHOSPHATASE AND USE THEREOF
WO2007101710A1 (en) 2006-03-09 2007-09-13 Cenix Bioscience Gmbh Use of inhibitors of scavenger receptor class proteins for the treatment of infectious diseases
EP1832283A1 (en) * 2006-03-09 2007-09-12 Cenix Bioscience GmbH Use of inhibitors of scavenger receptor class proteins for the treatment of infectious diseases
KR100787131B1 (en) 2006-07-04 2007-12-21 한국생명공학연구원 Compounds that inhibit hif-1 activity the method for preparation thereof and the pharmaceutical composition containing them as an effective component
AU2007276763B2 (en) * 2006-07-24 2011-03-17 University Of Maryland, Baltimore Heme oxygenase inhibitors and methods of therapeutic use
EP1886685A1 (en) 2006-08-11 2008-02-13 INSERM (Institut National de la Santé et de la Recherche Médicale) Methods, uses and compositions for modulating replication of hcv through the farnesoid x receptor (fxr) activation or inhibition
KR100786336B1 (en) * 2007-10-30 2007-12-14 한국생명공학연구원 Compounds that inhibit hif-1 activity, the method for preparation thereof and the pharmaceutical composition containing them as an effective component
WO2010010027A1 (en) * 2008-07-23 2010-01-28 Vib Vzw Antifungal compounds
KR101145206B1 (en) * 2008-11-10 2012-05-25 건국대학교 산학협력단 THE USE OF 4-CYCLOHEXYL- IMINOMETHYL-BENZENE-1,3-DIOL AS INHIBITOR OF beta-KETOACYL ACYL CARRIER PROTEIN SYNTHASE III (KAS III)
WO2012107589A1 (en) 2011-02-11 2012-08-16 INSERM (Institut National de la Santé et de la Recherche Médicale) Methods and pharmaceutical compositions for the treatment and prevention of hcv infections

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5981184A (en) * 1994-12-02 1999-11-09 Byk Gulden Lomberg Chemische Fabrik Gmbh Screening kit and process for determining action of substances inhibiting the P-type ATPase activity of Helicobacter pylori
AU1586997A (en) * 1996-02-20 1997-09-10 Inka Brockhausen Human serum lectin - induced apoptosis and method for detecting apoptosis
US5759795A (en) * 1996-03-08 1998-06-02 Schering Corporation Assay for determining inhibitors of ATPase
AU738194B2 (en) * 1997-12-05 2001-09-13 Pharmacia & Upjohn Company Fluorescence-based high throughput screening assays for protein kinases and phosphatases

Also Published As

Publication number Publication date
EP1206568A2 (en) 2002-05-22
WO2001016357A3 (en) 2001-11-29
WO2001016357A2 (en) 2001-03-08

Similar Documents

Publication Publication Date Title
AU7511800A (en) Novel target for antiparasitic agents and inhibitors thereof
AU7136900A (en) System for maintaining precomputed views
GB9900416D0 (en) Inhibitors
AU5991699A (en) Quinolizinones as integrin inhibitors
AU6111000A (en) Inhibitors of viral helcase
AU3074500A (en) Proteasome inhibitors
HK1041287A1 (en) Herbicide target gene and methods
AU9059798A (en) Urokinase inhibitors
EP1116800A4 (en) Sputtering target
AU2001236052A1 (en) Urease inhibitors
AU2576501A (en) Protein kinase inhibitors
AUPP982399A0 (en) Mmp inhibitor
AU7961300A (en) Kainic acid neurocytotoxicity inhibitors
AU7126900A (en) Enzyme inhibitors
AU5013200A (en) Target independent assay systems and methods
AU3235100A (en) Prothease inhibitors
GB9924522D0 (en) Enzyme inhibitors
AU3583000A (en) Method for direct steelmaking
AU6992500A (en) Alphavbeta3 integrin inhibitors
AU6422798A (en) Stabilized urease inhibitor
AU1474801A (en) Protease inhibitors
AU2373600A (en) Novel spla2 inhibitors
AU3888200A (en) Protease inhibitors
AU1474601A (en) Protease inhibitors
AU4066900A (en) Protease inhibitors

Legal Events

Date Code Title Description
MK6 Application lapsed section 142(2)(f)/reg. 8.3(3) - pct applic. not entering national phase